A peer-reviewed study in the Journal of Endocrinology confirming that AOD9604 produces lipolysis and increases fat oxidation in obese mice via the beta-adrenergic pathway, with effects comparable to full-length HGH but without the insulin-disrupting side effects provided early mechanistic validation that informed the human trials
In summary, EGCG shows great potential as a natural antiviral agent, particularly against liver-associated viruses, and its combination with existing antiviral therapies could offer a novel therapeutic approach for treating viral hepatitis and liver cancer, as well as other viral infections
Um, Marissa Liza: and then of course, again, I'm playing devil's advocate here, right
Both are unapproved research chemicals, and both appear on the WADA prohibited list under S2, so they carry no approved-therapeutic status of any kind